Table 1.
Characteristics of the patients with cervical adenocarcinoma
| Number of patients | n = 82 |
|---|---|
| Age (years) median (range) | 50.4 (30–85) |
| FIGO stage n, (%) | |
| IA | 5 (6.1) |
| IB | 48 (58.5) |
| IIA | 5 (6.1) |
| IIB | 14 (17.1) |
| IIIA | 0 |
| IIIB | 8 (9.8) |
| IVA | 0 |
| IVB | 2 (2.4) |
| Tumor size (cm) median (range) | 32.7 (0–80) |
| Unknown | 5 |
| Tumor size | |
| < 4 cm | 49 (59.6) |
| ≥ 4 cm | 33 (40.4) |
| LVI | |
| Yes | 39 (47.6) |
| No | 29 (35.4) |
| Unknown | 14 (17.0) |
| Metastatic paraaortic LN | |
| Yes | 17 (20.7) |
| No | 65 (79.3) |
| Metastatic pelvic LN | |
| Yes | 3 (3.7) |
| No | 79 (92.3) |
| Metastasis distance | |
| Yes | 1 (1.2) |
| No | 81 (98.8) |
| Treatment | |
| Operation only | 24 (29.2) |
| Operation + adjuvant (RT or CCRT or CT) | 48 (58.5) |
| Radiotherapy (RT, CCRT) | 8 (9.8) |
| Chemotherapy | 2 (2.5) |
| Recurrence within 5 years | |
| Yes | 20 (24.4) |
| No | 60 (75.6) |
| Death within 5 years | |
| Yes | 19 (23.2) |
| No | 63 (76.8) |
LVI lymphovascular invasion, RT radiotherapy, CCRT concurrent chemoradiotherapy, CT chemotherapy